Concepedia

Massimiliano Manganini

MM

Statistics

Publications

10

Citations

795

H-Index

10

Active since

2000

Affiliations

Mario Negri Institute for Pharmacological Research(Current)

University of Bergamo

University of Milan

University of Milano-Bicocca

Massimiliano Manganini is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, cell biology, and chromatin.

Top concepts

Publications per year

2000–2013

10

Publications

10

Mechanism of Action of Type II, Glycoengineered, Anti-CD20 Monoclonal Antibody GA101 in B-Chronic Lymphocytic Leukemia Whole Blood Assays in Comparison with Rituximab and Alemtuzumab

Luca Bologna, Elisa Gotti, Massimiliano Manganini et al. · The Journal of Immunology · 2011 · 198 citations · Full text

, , +17

The role of complement in the therapeutic activity of rituximab in a murine B lymphoma model homing in lymph nodes.

Josée Golay, Elena Cittera, Nicola Di Gaetano et al. · PubMed · 2006 · 130 citations

Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2.

Josée Golay, Massimiliano Manganini, Valeria Facchinetti et al. · PubMed · 2003 · 113 citations

Characterization of CD20-Transduced T Lymphocytes as an Alternative Suicide Gene Therapy Approach for the Treatment of Graft-Versus-Host Disease

Marta Serafini, Massimiliano Manganini, Gianmaria Borleri et al. · Human Gene Therapy · 2004 · 111 citations

Effect of alemtuzumab on neoplastic B cells.

Josée Golay, Massimiliano Manganini, Alessandro Rambaldi et al. · PubMed · 2004 · 87 citations

Rows per page

1–5 of 10